CD4 and neoplasm: To look for more subtle differences, we pooled the TCR sequencing data for each of the nine sources of CD4+ T cell subsets (Treg, naive and memory CD4+ T cells from tumor, LN and blood) from all five patients15 and used unsupervised clustering to compare their TCR-α and TCR-β usage16.